A novel BMP2-coprecipitated, layer-by-layer assembled biomimetic calcium phosphate particle: a biodegradable and highly efficient osteoinducer.
暂无分享,去创建一个
Yi Liu | D. Wismeijer | Gang Wu | Y. Liu | Yi Liu | Yuanna Zheng | Tie Liu | Yuelian Liu
[1] S. Bose,et al. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. , 2012, Acta biomaterialia.
[2] T. Kawai,et al. Granule size-dependent bone regenerative capacity of octacalcium phosphate in collagen matrix. , 2012, Tissue engineering. Part A.
[3] E. Hunziker,et al. Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. , 2011, Bone.
[4] K. de Groot,et al. Biomimetic coatings for bone tissue engineering of critical-sized defects , 2010, Journal of The Royal Society Interface.
[5] E. Hunziker,et al. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. , 2010, Biomaterials.
[6] E. Hunziker,et al. Biomimetic coating of organic polymers with a protein-functionalized layer of calcium phosphate: the surface properties of the carrier influence neither the coating characteristics nor the incorporation mechanism or release kinetics of the protein. , 2010, Tissue engineering. Part C, Methods.
[7] Maryam Tabrizian,et al. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.
[8] Maryam Tabrizian,et al. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering , 2009, Biotechnology Letters.
[9] Jin-Woo Park,et al. Bone formation with various bone graft substitutes in critical-sized rat calvarial defect. , 2009, Clinical oral implants research.
[10] J. M. Badura,et al. Short-term Osteoclastic Activity Induced by Locally High Concentrations of Recombinant Human Bone Morphogenetic Protein–2 in a Cancellous Bone Environment , 2009, Spine.
[11] K. Marra,et al. Bone Morphogenetic Protein 2 Therapy for Craniofacial Surgery , 2008, The Journal of craniofacial surgery.
[12] F. Schwarz,et al. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. , 2008, Clinical oral implants research.
[13] Charles A Powell,et al. Foreign Body Reaction to Anorganic Bovine Bone and Autogenous Bone With Platelet‐Rich Plasma in Guided Bone Regeneration , 2008 .
[14] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[15] E. Hunziker,et al. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. , 2007, Biomaterials.
[16] K. Shakesheff,et al. Polymer carriers for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.
[17] E. Hunziker,et al. Delivery Mode and Efficacy of BMP-2 in Association with Implants , 2007, Journal of dental research.
[18] S. Glassman,et al. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.
[19] B. Ratner,et al. The role of osteopontin in foreign body giant cell formation. , 2005, Biomaterials.
[20] E. Hunziker,et al. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. , 2005, Bone.
[21] Zhuoran Zhao,et al. Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7 , 2005, Journal of cellular biochemistry.
[22] Buddy D Ratner,et al. Biomaterials: where we have been and where we are going. , 2004, Annual review of biomedical engineering.
[23] Pierre Layrolle,et al. Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. , 2004, Tissue engineering.
[24] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[25] D. Kohn,et al. Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. , 2002, Journal of biomedical materials research.
[26] G Pradal,et al. Cellular mechanisms of calcium phosphate ceramic degradation. , 1999, Histology and histopathology.
[27] J. Lou,et al. Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] T. Kokubo,et al. Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. , 1996, Biomaterials.
[29] E R Weibel,et al. Recent stereological methods for cell biology: a brief survey. , 1990, The American journal of physiology.
[30] H J Gundersen,et al. The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.
[31] T. N. Salthouse,et al. Some aspects of macrophage behavior at the implant interface. , 1984, Journal of biomedical materials research.
[32] B. D. de Lumen,et al. Fluorescein-hemoglobin as a substrate for cathepsin D and other proteases. , 1970, Analytical biochemistry.
[33] J. Lindhe,et al. Socket grafting with the use of autologous bone: an experimental study in the dog. , 2011, Clinical oral implants research.
[34] P. Schlesinger,et al. Calcium signalling and calcium transport in bone disease. , 2007, Sub-cellular biochemistry.
[35] J. Granjeiro,et al. Rat subcutaneous tissue response to macrogranular porous anorganic bovine bone graft. , 2006, Brazilian dental journal.
[36] E. Bonucci,et al. Tartrate-resistant acid phosphate activity as osteoclastic marker: Sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry , 2005, Osteoporosis International.